Senores Pharmaceuticals Schedules Board Meeting on 29th Oct'26 for Q2 Results
Senores Pharmaceuticals Ltd 路 Intimation 路 29 Oct 2026, 5:30 am
Senores Pharmaceuticals Schedules Board Meeting on 29th Oct'26 for Q2 Results Senores Pharmaceuticals Limited announced that its Board of Directors will meet on 29th Oct'26 to consider and approve the un-audited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Additionally, the trading window for dealing in company securities has been closed since 1st Oct'26 and will reopen 48 hours after the financial results are approved and submitted to stock exchanges.
Original exchange filing (PDF)
More announcements from Senores Pharmaceuticals Ltd
- We are pleased to announce that the manufacturing facility of our Subsidiary Company., Ratnatris Pharmaceuticals Private Limited has been awarded with the prestigious PIC/S GMP certification .... 路 18 Nov 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding transcript of earnings conference call held on October 29, 2026 路 05 Nov 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding audio recording of earnings conference call for quarter ended September 30, 2026 路 30 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds raised through preferential issue of convertible .... 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds of public issue for quarter ended on September 30, 2026 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding Monitoring Agency report for the quarter ended September 30, 2026 路 29 Oct 2026
- We enclose herewith the Investor Presentation for Q2 & H1FY27 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding Appointment of joint Statutory Auditor of the Company 路 29 Oct 2026
